Search
Now showing items 31-38 of 38
DbpA compositions and methods of use
(United States. Patent and Trademark Office, 2001-11-06)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
SdrC protein from Staphylococcus aureus and diagnostic kits including same
(United States. Patent and Trademark Office, 2010-10-19)
An isolated extracellular matrix-binding protein, designated as SdrC and its corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or antigenic portions ...
Compositions and methods of enhancing immune responses
(United States. Patent and Trademark Office, 2016-01-05)
Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
Decorin binding protein compositions and methods of use
(United States. Patent and Trademark Office, 1998-12-29)
Disclosed are the dbp gene and dbp-derived nucleic acid segments from Borrelia burgdorferi, the etiological agent of Lyme disease, and DNA segments encoding dbp from related borrelias. Also disclosed are decorin binding ...
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
(United States. Patent and Trademark Office, 2017-01-17)
The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
(United States. Patent and Trademark Office, 2017-08-15)
The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, ...
Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
(United States. Patent and Trademark Office, 2020-06-16)
Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...
Yeast Vaccine Vector Including Immunostimulatory And Antigenic Polypeptides And Methods Of Using The Same
(United States. Patent and Trademark Office, 7/12/2022)
Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...